These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25889131)

  • 21. Psoriasis as a systemic disease.
    Grozdev I; Korman N; Tsankov N
    Clin Dermatol; 2014; 32(3):343-50. PubMed ID: 24767182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dyslipidemia in Overweight and Obese School-Aged Children.
    Finn P
    NASN Sch Nurse; 2015 Sep; 30(5):255-7. PubMed ID: 26219905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between obesity and pediatric psoriasis.
    Hunjan MK; Maradit Kremers H; Lohse C; Tollefson M
    Pediatr Dermatol; 2018 Sep; 35(5):e304-e305. PubMed ID: 30024063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood-onset psoriasis: association with future cardiovascular and metabolic comorbidities.
    Mahé E; Maccari F; Beauchet A; Lahfa M; Barthelemy H; Reguiaï Z; Beneton N; Estève E; Chaby G; Ruer-Mulard M; Steiner HG; Pauwels C; Avenel-Audran M; Goujon-Henry C; Descamps V; Begon E; Sigal ML;
    Br J Dermatol; 2013 Oct; 169(4):889-95. PubMed ID: 23937622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM; Moran A
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psoriasis, metabolic syndrome and its components].
    Ortonne JP
    Ann Dermatol Venereol; 2008 Feb; 135 Suppl 4():S235-42. PubMed ID: 18466790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoriasis and metabolic syndrome.
    Takahashi H; Iizuka H
    J Dermatol; 2012 Mar; 39(3):212-8. PubMed ID: 22035413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of overweight, obesity and metabolic syndrome components in children, adolescents and young adults with type 1 diabetes mellitus.
    Pinhas-Hamiel O; Levek-Motola N; Kaidar K; Boyko V; Tisch E; Mazor-Aronovitch K; Graf-Barel C; Landau Z; Lerner-Geva L; Frumkin Ben-David R
    Diabetes Metab Res Rev; 2015 Jan; 31(1):76-84. PubMed ID: 24827815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between childhood obesity cut-offs and metabolic and vascular comorbidities: comparative analysis of three growth standards.
    Martínez-Costa C; Núñez F; Montal A; Brines J
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():75-83. PubMed ID: 23808870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriasis and the metabolic syndrome.
    Gisondi P; Fostini AC; Fossà I; Girolomoni G; Targher G
    Clin Dermatol; 2018; 36(1):21-28. PubMed ID: 29241748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoriasis and the metabolic syndrome.
    Cohen AD; Gilutz H; Henkin Y; Zahger D; Shapiro J; Bonneh DY; Vardy DA
    Acta Derm Venereol; 2007; 87(6):506-9. PubMed ID: 17989888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on pediatric psoriasis.
    Silverberg NB
    Cutis; 2015 Mar; 95(3):147-52. PubMed ID: 25844780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis.
    Rosa DJ; Machado RF; Matias FA; Cedrim SD; Noronha FL; Gaburri D; Gamonal A
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):348-53. PubMed ID: 21545540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
    Wisse BE
    J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children.
    Mauras N; Delgiorno C; Kollman C; Bird K; Morgan M; Sweeten S; Balagopal P; Damaso L
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1060-8. PubMed ID: 20061420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary determinants of subclinical inflammation, dyslipidemia and components of the metabolic syndrome in overweight children: a review.
    Zimmermann MB; Aeberli I
    Int J Obes (Lond); 2008 Dec; 32 Suppl 6():S11-8. PubMed ID: 19079275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of psoriasis in children.
    Tollefson MM
    Pediatr Clin North Am; 2014 Apr; 61(2):261-77. PubMed ID: 24636645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory assessment of cardiometabolic risk in overweight and obese children.
    Sypniewska G
    Clin Biochem; 2015 Apr; 48(6):370-6. PubMed ID: 25583095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.